Inventor · disambiguated record
Sanjaya Singh
Also filed as: SINGH I SANJAYA · SINGH SANJAYA
71 granted patents·76 pending applications·590 citations·filing 2004–2025
99Inventor score
Files withJANSSEN BIOTECH INC56BOEHRINGER INGELHEIM INT30GENENTECH INC14FUNG SEK CHUNG7JANSSEN PHARMACEUTICA NV7
Top patents by PatentIndex Score
147 records- 0196US11236155B2Antibodies to pyroglutamate amyloid-β and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 1, 2022·4 cites·23 claims
- 0296US8591900B2Anti-CD40 antibodiesBARRETT RACHEL REBECCA·Filed 2011·Granted Nov 26, 2013·53 cites·42 claims
- 0396US8088618B2Anti-IL 13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2008·Granted Jan 3, 2012·41 cites·37 claims
- 0495US9090696B2Polynucleotides encoding anti-CD40 antibodiesBARRETT RACHEL REBECCA·Filed 2013·Granted Jul 28, 2015·33 cites·4 claims
- 0595US8372403B2Humanized anti-factor D antibodies and uses thereofGENENTECH INC·Filed 2012·Granted Feb 12, 2013·17 cites·31 claims
- 0695US8067002B2Humanized anti-factor D antibodiesAN LING-LING·Filed 2007·Granted Nov 29, 2011·29 cites·28 claims
- 0794US9605065B2Anti-IL13 antibodies and uses thereofGENENTECH INC·Filed 2013·Granted Mar 28, 2017·17 cites·24 claims
- 0894US7935791B2Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseasesGENENTECH INC·Filed 2007·Granted May 3, 2011·25 cites·11 claims
- 0993US8604171B2High affinity, anti-human IgE antibodiesSINGH SANJAYA·Filed 2012·Granted Dec 10, 2013·28 cites·12 claims
- 1093US8486398B2Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compoundsVAN RYN JOANNE·Filed 2011·Granted Jul 16, 2013·27 cites·31 claims
- 1193US8252284B2High affinity, anti-human IgE antibodiesSINGH SANJAYA·Filed 2009·Granted Aug 28, 2012·31 cites·11 claims
- 1293US8193329B2Nucleic acids encoding anti-factor D antibodiesAN LING-LING·Filed 2011·Granted Jun 5, 2012·15 cites·44 claims
- 1393US8067199B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2004·Granted Nov 29, 2011·39 cites·50 claims
- 1492US8778346B2Anti-IL-23 antibodiesBARRETT RACHEL REBECCA·Filed 2011·Granted Jul 15, 2014·26 cites·46 claims
- 1592US8187604B2Methods of treating with anti-factor D antibodiesAN LING-LING·Filed 2011·Granted May 29, 2012·12 cites·39 claims
- 1692US7915390B2Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseasesGENENTECH INC·Filed 2007·Granted Mar 29, 2011·22 cites·19 claims
- 1792US7531169B2High affinity anti-human IgE antibodiesTANOX INC·Filed 2004·Granted May 12, 2009·43 cites·17 claims
- 1891US12077592B2GPRC5D chimeric antigen receptors and cells expressing the sameJANSSEN BIOTECH INC·Filed 2020·Granted Sep 3, 2024·3 cites·36 claims
- 1991US11667712B2Materials and methods for modulating t cell mediated immunityJANSSEN BIOTECH INC·Filed 2020·Granted Jun 6, 2023·2 cites·41 claims
- 2091US8753826B2Methods of detecting factor D with anti-factor D antibodiesGENENTECH INC·Filed 2013·Granted Jun 17, 2014·8 cites·32 claims
- 2191US8734801B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2011·Granted May 27, 2014·10 cites·32 claims
- 2290US12180278B2Antibody targeting CD22 and CD79BJANSSEN BIOTECH INC·Filed 2022·Granted Dec 31, 2024·2 cites·29 claims
- 2390US8734797B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2011·Granted May 27, 2014·10 cites·21 claims
- 2489US11981932B2Materials and methods for the manufacture of pluripotent stem cellsJANSSEN BIOTECH INC·Filed 2021·Granted May 14, 2024·1 cites·12 claims
- 2588US11384151B2CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsABLYNX NV·Filed 2019·Granted Jul 12, 2022·2 cites·11 claims
- 2688US9441036B2Anti-IL-23 antibodiesBARRETT RACHEL REBECCA·Filed 2014·Granted Sep 13, 2016·10 cites·14 claims
- 2788US9067994B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2011·Granted Jun 30, 2015·6 cites·19 claims
- 2887US9034822B2Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compoundsVAN RYN JOANNE·Filed 2013·Granted May 19, 2015·10 cites·9 claims
- 2987US8821871B2Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereofVAN RYN JOANNE·Filed 2012·Granted Sep 2, 2014·12 cites·19 claims
- 3086US11434287B2Anti-IL13 antibodies and uses thereofGENENTECH INC·Filed 2019·Granted Sep 6, 2022·2 cites·12 claims
- 3186US11242394B2Anti-CD40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2018·Granted Feb 8, 2022·3 cites·43 claims
- 3286US9035029B2CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsSINGH SANJAYA·Filed 2013·Granted May 19, 2015·7 cites·36 claims
- 3386US2025101093A1Anti-il-23 antibodiesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3485US10385134B2CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Aug 20, 2019·3 cites·18 claims
- 3585US10202448B2Anti-IL-23 antibodiesBOEHRINGER INGELHEIM INT·Filed 2016·Granted Feb 12, 2019·4 cites·9 claims
- 3684US8148106B2Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseasesFUNG SEK CHUNG·Filed 2011·Granted Apr 3, 2012·5 cites·24 claims
- 3783US11897964B2Anti-PSGL-1 antibodies and uses thereofALTRUBIO INC·Filed 2021·Granted Feb 13, 2024·1 cites·5 claims
- 3882US12221487B2Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsABLYNX NV·Filed 2022·Granted Feb 11, 2025·0 cites·20 claims
- 3981US12129310B2Materials and methods for enhanced linker targetingJANSSEN BIOTECH INC·Filed 2023·Granted Oct 29, 2024·0 cites·16 claims
- 4081US10793629B2Compound targeting IL-23A and TNF-alpha and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Granted Oct 6, 2020·1 cites·35 claims
- 4181US10280231B2Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereofBOEHRINGER INGELHEIM INT·Filed 2016·Granted May 7, 2019·3 cites·18 claims
- 4281US9783612B2CX3CR1-binding polypeptidesBOEHRINGER INGELHEIM INT·Filed 2016·Granted Oct 10, 2017·2 cites·12 claims
- 4381US8329868B2Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseasesFUNG SEK CHUNG·Filed 2012·Granted Dec 11, 2012·3 cites·6 claims
- 4481US8187839B2Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseasesLI KANG·Filed 2011·Granted May 29, 2012·4 cites·15 claims
- 4580US9458235B2Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptidesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Oct 4, 2016·2 cites·2 claims
- 4680US2025320286A1Antibodies to pyroglutamate amyloid-b and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2025·Application pending·0 cites
- 4779US12492256B2Methods and compositions for modulating beta chain mediated immunityJANSSEN BIOTECH INC·Filed 2024·Granted Dec 9, 2025·0 cites·28 claims
- 4879US11267880B2Anti-Sema3A antibodies and their uses for treating eye or ocular diseasesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Mar 8, 2022·1 cites·26 claims
- 4979US10793634B2Anti-TrkB antibodiesBOEHRINGER INGELHEIM INT·Filed 2018·Granted Oct 6, 2020·3 cites·38 claims
- 5079US2023382988A1Compound targeting il-23a and tnf-alpha and uses thereofBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
Showing the top 50 of 147 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sanjaya Singh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →